PRACTICING TO THE TOP SCOPE OF UROLOGY PRACTICE AND ADVANCING TREATMENT AND PATIENT CARE THROUGH RESEARCH
People In Health Care Segment
Filmed in Melbourne | March 2025
With
Michael Cromer,
Urology Nurse Practitioner
Australian Prostate Cancer (APC) & Western Urology,
Melbourne
Michael is a urology nurse practitioner with a special interest in prostate cancer survivorship, and has worked in urology for the past ten years. Michael has completed the Prostate Nursing Care course at Latrobe University, Graduate Certificate of Health with a specialisation in Scheduled Medicines (USQ), and the Master of Nursing (Flinders) to become a Nurse Practitioner in 2024.
As a Urology Nurse Practitioner he divides his time between the Australian Prostate Centre and Western Urology.
He also has particular interest in sexual function, continence management and procedures under local anaesthetic. Currently Michael is involved in several research projects relating to prostate cancer testing and treatment, BPH and sexual function.
Michael is a member of the Australia & New Zealand Urological Nurses Society (ANZUNS), Victorian Urological Nurses Society (VUNS), and the Australian College of Nursing (ACN).
Source: supplied and edited
You Might also like
- 
					
					Sovereign capability upliftedSkilled labour, in particular skilled in the manufacture of MTP products, namely competency in Good Manufacturing Practice (GMP), was identified as one of the key priorities, according to Jarrod Belcher, Director of the REDI Program at MTPConnect. Through a competitive process, MTPConnect selected additional industry training providers to deliver new programs addressing key skills gaps in the sector workforce. Launched in September 2022, one of these programs is GMP Uplift developed by the Centre for Biopharmaceutical Excellence (CBE). CBE bring experience across large and small Biologics, Pharmaceuticals and Regenerative Medicine companies, both in consulting and GMP related enterprise training. CBE staff also have extensive experience in GMP operations, compliance, auditing and QMS design, a wide industry network for guest lecturers and readily available case studies. 
- 
					
					Maximising benefits, minimising harms in population health screeningPopulation screening is an important contributor to advancing health outcomes through the early detection of and successful intervention for chronic disease. The evolution of science, technology and evidence relating to diseases which are or may be amenable to a population screening approach deserve broad discussion and the sharing of expertise and evidence. They also warrant close scrutiny in context of health policy and health resource allocation considerations. In March, Public Health Association of Australia (PHAA) convened Screening Conference Conference 2025 with the theme of ‘Population Screening for Chronic Disease – Maximising Benefits, Minimising Harms’. 
- 
					
					Analogy of the system, rather than the ED front door“The problem of blockages shows up in ambulance ramping and long wait times, but this is a complex issue requiring whole-of-health system solutions,” according to Professor Hugh Grantham, Chair of Emergency Medicine Foundation in an interview with Australian Health Journal. 
 
		
		 
					
																				
					 
					
																				
					